top of page
klklklll.PNG
Medytrak's remote patient monitoring delivers real-time health tracking via NFC-enabled cards, customizable questionnaires, and secure browser access. It enables early detection, automated alerts, and seamless data insights for clinicians without apps or manual entry
Medytrak's remote patient monitoring delivers real-time health tracking via NFC-enabled cards, customizable questionnaires, and secure browser access. It enables early detection, automated alerts, and seamless data insights for clinicians without apps or manual entry
Medytrak's remote monitoring uses NFC technology and smartphones to track patient symptoms, medication compliance, and health status in real-time without requiring app downloads or complex passwords

Reduce Trial Dropouts & Site Paperwork

Real-time oversight for multi-site trials

with automated SMS, ePROs, and geo-stamped audit trails.

Built for Ireland & UK regulatory requirements


Cut Paperwork:  Automated SMS & electronic data capture.

Live Tracking:  Monitor recruitment & retention on one dashboard.

Remote Ready:  Enable decentralized trials with secure monitoring.

Speak directly with our clinical trials team
unnamed (2).png
Medytrak revolutionizes clinical trials in Ireland through advanced remote onboarding and monitoring capabilities, enabling researchers to conduct studies efficiently without traditional site visits. The platform's unique NFC technology allows patients to complete assessments from home using smartphones, eliminating app downloads and complex passwords. Real-time data collection provides researchers with immediate patient insights, symptom tracking, and comprehensive progress monitoring between consultations. Remote onboarding reduces patient travel burden while maintaining regulatory compliance and data security. Clinical teams benefit from customizable questionnaires, photo/video uploads for wound monitoring, and automated alerts for protocol deviations. Medytrak's browser-based system supports early discharge models, reduces hospital wait times, and enables decentralized trial management. Choose Medytrak for cost-effective, patient-centric clinical trials with enhanced engagement, im
vgfghfgg.PNG
ce.PNG

Our software is classified as a medical device

and bears the CE mark, certifying compliance

with EU MDR 2017/745 for safety, performance, and quality

crest.PNG

We’re committed to safeguarding our customers’ data and maintaining the highest security standards. That’s why we recently engaged a CREST-approved cyber security firm, to conduct a thorough penetration test of our systems. This independent assessment confirms our dedication to providing a secure and trusted experience for all our users.

safsfsfasf.PNG

We’re dedicated to protecting personal data and upholding the strictest standards of privacy and compliance. As part of our ongoing commitment, we’ve successfully achieved GDPR 2025 accreditation, demonstrating that our policies, systems, and processes meet the highest levels of data protection. This recognition reinforces our promise to keep customer information secure, transparent, and handled with utmost care.

Gemini_Generated_Image_dlhr5ndlhr5ndlhr.png

Medytrak  is classified as a Class I Software as a Medical Device (SaMD) under U.S. regulations and is listed with the U.S. Food and Drug Administration (FDA) as a Medical Device Data System (MDDS) in accordance with 21 CFR 880.6310. Medytrak is exempt from premarket notification requirements and is registered and listed with the FDA pursuant to 21 CFR Part 807.

PATENT PENDING
NO.63116634
PATENT PENDING
NO.63118940
ALL RIGHTS RESERVED

MediCareTags Limited

A private company limited by shares.

Registered in Ireland No 694928

Registered Office Salthill House, Salthill, Galway, Ireland.

bottom of page